Weekly Briefing

Men's Health Briefing: November 16, 2026

Covers November 10 – 16, 2026

The short version

This week

FTCNovember 10, 2026

Five more states join the FTC's lawsuit against Hims & Hers

The Federal Trade Commission announced on November 10 that Arizona, Florida, Nebraska, Ohio, and Wisconsin have joined its case against Hims & Hers as co-plaintiffs, alongside Utah and California. The FTC first sued in July 2026. The amended complaint, filed in federal court in Northern California after a 2-0 Commission vote, alleges that Hims shared sensitive health information with advertising platforms, including Meta and Snap, while telling customers their information was private; that it charged for prescriptions almost immediately after an intake form was submitted without clearly saying so; and that it made subscriptions hard to cancel. It adds claims under the five new states' consumer protection laws.

These are allegations, and the court has not ruled on them. Hims told reporters it will vigorously defend itself and called the new claims follow-on claims built on the same flawed allegations. Bloomberg reported in October that a hearing on Hims's request to dismiss the case was set for January 7; the FTC's release does not mention it.

What it means for youNothing in this filing changes your prescription or treatment. If you use any telehealth service, it's worth reading its privacy policy, checking your ad and tracking settings, and confirming when you will be charged and how to cancel before you finish an intake form. Our Hims review covers its pricing and the FTC case, and our comparison of online TRT providers sets out how other clinics bill.

Sources: FTC press release · FTC case page · MLex · PYMNTS · Related: Our Hims review · Best online TRT providers

We also checked FDA press announcements, FTC releases, and the Federal Register for November 10–16. We found no new FDA action on testosterone, GLP-1s, erectile dysfunction, or hair-loss drugs, and no DEA telemedicine rule (see below). On November 12 the DEA published an interim final rule placing oveporexton (Orzeyful), a narcolepsy type 1 drug the FDA approved on August 5, in Schedule IV. It affects people with that condition, not testosterone prescribing. (Federal Register · Sleep guide)

Health topics

Supplements & “male enhancement” productsNovember 12, 2026

Two more “male enhancement” products recalled for hidden erectile dysfunction drugs

The FDA posted two company recall notices on November 12. Game Changer Products of Tampa, Florida, recalled all lots of 10 Day Forecast Capsules 3200mg after FDA analysis found undeclared sildenafil (the active ingredient in Viagra) and acetaminophen. The capsules were sold nationwide, including in Puerto Rico, Guam, and the Northern Mariana Islands, through the company's website, eBay, and one store in Minnesota, from at least October 2021 through October 17, 2026. Eros Apothecary of Indio, California, recalled one batch (241020) of Candy Power For Man Organic Honey, sold on eBay from April 27 to July 20, 2026, after FDA testing found undeclared tadalafil (the active ingredient in Cialis).

Both notices warn that these drugs can interact with nitrates, such as nitroglycerin, and cause a dangerous drop in blood pressure. Nitrates are often taken by people with diabetes, high blood pressure, high cholesterol, or heart disease. The 10 Day Forecast notice adds that extra acetaminophen can cause liver damage, especially in people already taking it. Game Changer says it has received no reports of adverse events; the Eros notice doesn't report any. These are company announcements posted by the FDA, not studies, and they describe only the products tested. They follow the October 24 recall of Ultimate Forza Male Supplement for the same kind of problem.

What it means for youBoth companies tell customers to stop using the products and throw away what's left. If you've taken either one and have health concerns, contact your doctor, and tell them if you take a nitrate or any heart or blood pressure medicine. A product sold as a supplement can contain prescription drugs that aren't on the label. Our PDE5 safety guide explains the nitrate risk, and our testosterone boosters guide covers tainted supplements.

Sources: FDA: 10 Day Forecast recall · FDA: Candy Power For Man recall · Related: PDE5 inhibitor safety · Testosterone boosters · Supplements guide

Hair lossOctober 2, 2026

Review finds no clear link between finasteride-type drugs and suicide, but the evidence is weak and mostly from prostate patients

Researchers at the University of Campania in Naples pooled observational studies of 5-alpha reductase inhibitors, the drug class that includes finasteride (used for hair loss and an enlarged prostate) and dutasteride. Their review included 11 studies covering about 4.07 million men in Asia, Europe, and North America. Compared with non-users or men taking a different prostate drug, users showed no statistically significant difference in suicide (hazard ratio 1.07, with a range from 0.76 to 1.51, pooled from four studies) or in a combined measure of anxiety, depression, and self-harm (1.23, range 0.74 to 2.03). It was published October 2, 2026 in Frontiers in Urology.

The limits matter. Most of the studies looked at older men treated for an enlarged prostate; only a few included men taking these drugs for hair loss, and the authors did not report separate results for them. The studies differed widely, and the authors rated the certainty of the evidence as very low for most outcomes. Because the studies were observational, they can't rule out a risk in some men. The authors received no funding and reported no conflicts of interest, and they call for continued monitoring. This review doesn't change the finasteride label, which lists depression and suicidal thoughts as reported side effects.

What it means for youThis adds to the evidence but doesn't settle the question, especially for younger men using finasteride for hair loss. If you notice changes in your mood while taking finasteride or dutasteride, tell your prescriber, and talk to them before stopping or changing any medicine. Our getting help page lists where to turn. If you are in crisis or thinking about suicide, call or text 988 (in the US) to reach the Suicide & Crisis Lifeline.

Sources: Frontiers in Urology (full text, PubMed Central) · DOI · Related: Getting help · Depression and anxiety · Finasteride and PSA

What we're watching

All briefings →

This briefing summarizes publicly reported news and government actions for general education. It is not medical or legal advice. Legal allegations described here have not been proven unless stated. Always confirm details with the original sources and talk to a licensed physician before changing any treatment.